Taysha Gene Therapies Inc (TSHA) Biznesning o‘zini qoplash muddati

Taysha Gene Therapies Inc (TSHA) brendining ramzi va logotipi

Taysha Gene Therapies (TSHA) kompaniyasining investitsiya potentsiali dori vositalarini ishlab chiqish va ishlab chiqarishning barcha bosqichlarini tashqi pudratchilarga chuqur autsorsing qilishga asoslangan. Kompaniyaning P/E koeffitsiyenti diapazoni bozor kutganlarini vizuallashtiradi, bunda ko'rsatkich -8.30 darajasida turibdi. Ushbu model CMO va CRO larga to'liq bog'liqlik bilan tasdiqlanadi, joriy narx belgilash imkoniyatining yo'qligi esa Rett sindromi terapiyasi FDA tomonidan tasdiqlangach, premium narxlarni belgilash istiqbollari bilan qoplanadi.

Taysha Gene Therapies (TSHA) - P/E multiplikatori 04.07.2022dan 18.11.2026gacha

Taysha Corp (TSHA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning jamlanma tahlili:TSHA (Taysha Gene Therapies Inc)
Taysha yetakchi tovari

P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi va u joriy aksiya narxining aksiya boshiga foyda nisbati sifatida hisoblanadi. Taysha Gene Therapies (TSHA) kompaniyasining bozor P/E koeffitsiyentini tahlil qilish orqali investor biznes uchun haddan tashqari ko'p to'lov darajasini baholaydi, bu esa Rett sindromi terapiyasini ishlab chiqishning yuqori xarajatlari va patentlar orqali intellektual mulkni himoya qilish sababli Taysha Gene Therapies (TSHA) uchun juda muhimdir.

Raqobatdosh kompaniyalar tahlili

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati WGS (GeneDx)|RARE: P/E multiplikatori|Beam Therapeutics Corp - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti SRPT|twistbioscience.com (TWST) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TXG|NTLA (Intellia) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Stoke STOK|BioLife (BLFS) - Kapitalizatsiyaning foydaga nisbati|wavelifesciences.com - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati MAZE|SION: P/E multiplikatori|PRME - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati